PEGASYS 135 micrograms, solution for injection in a pre-filled syringe 4 syringes of 0.5 ml
Active ingredients: Peginterferon alfa-2a
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Solution for injection4 syringes of 0.5 mlsous-cutanée
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- PEGASYS 135 microgrammes, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 4 seringue(s) préremplie(s) en verre de 0,5 ml avec aiguille(s)
- Marketing authorisation holder
- PHARMAAND (AUTRICHE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Apr 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67042907CIP73599598CIP133400935995988Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PEGINTERFÉRON ALFA-2Asolution | 135 microgrammes · 0,5 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.